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Virus-specific cytotoxic T  cells (CTL) recognize viral antigen  in conjunction 
with  products  of genes  of the  major  histocompatibility  complex  (MHC)  (1); 
however, the  nature  of the  viral  antigen(s)  recognized  by specific CTL  is not 
clear,  identification  of viral determinant(s)  recognized by CTL is an important 
issue; however, it has been difficult to demonstrate  CTL recognition  of target 
cells exposed to viral antigens. Previous studies (2) have indicated that the surface 
glycoproteins of Sendal virus were recognized by CTL, providing the fusion (F) 
protein was cleaved. Isolated viral surface glycoproteins were recognized on cell 
surfaces by CTL after incorporation into the cell membrane by liposomal carriers 
(3,  4),  and  by  DNA-mediated  gene  transfer  (5).  CTL  responses  to  internal 
influenza  viral  proteins have also been reported  (6,  7).  Extensive studies have 
been conducted (8) using influenza A virus infection as a model system, and two 
different subpopulations of CTL, crossreactive and subtype-specific, are induced. 
We previously reported (9) that an  influenza  virus-specific polypeptide (des- 
ignated c13 protein) produced in E.  coli induced H1  influenza subtype-specific 
memory and secondary H-2-restricted CTL responses in mice. The cl 3 protein 
is a  hybrid protein  of the  first  81  amino  acids of the  NS1  viral  nonstructural 
protein and the HA2 subunit of viral hemagglutinin  (HA) derived using genes 
from an  H1 N1  virus.  It is, therefore, conceivable that the c l 3 protein interacts 
with  cellular  membrane  to be presented  to CTL  precursors  along with  MHC 
products. In this study, we examined the ability of c 13 protein to render target 
cells  susceptible  to  lytic  activity  of influenza  virus-specific  CTL.  The  results 
showed that target cells exposed to c 13 protein were lysed by CTL in a subtype- 
specific and  H-2-restricted  manner,  suggesting  that  this  protein  interacts  with 
target cell membrane with its hydrophobic region, and is presented on the cell 
membrane  in  proper  conformation  with  H-2  antigens  for  recognition  by the 
influenza virus subtype-specific CTL. 
Materials and Methods 
Mice.  Male  BALB/cAnH (H-2  d) and  C3H/HeN (H-2  k) mice  were purchased  from 
Charles  River Breeding Laboratories, Inc. (Wilmington,  MA), and used at the age of 4- 
5 wk. 
Virus.  Influenza A viruses, PR8 (A/Puerto Rico/8/34 [H 1N 1  ]), A/BZ (A/Brazil/11/78 
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[H1NI]),  A/PC  (A/Port  Chalmers/l/73  [H3N2]),  and  a  recombinant  virus  A/X31 
(H3N2), were propagated in 9-d-old embryonated chicken eggs, as described previously 
(9). 
Production ofcl3 Protein.  c13 protein was produced in E. coli as described before (9). 
Briefly, plasmids containing DNA fragments complementary to the viral RNA of PR8 
virus were manipulated to achieve expression of c 13 protein, which is a hybrid of the first 
81 amino acids of NSl and HA2. Following lysis of the bacteria, two 0.1% deoxycholate 
extractions and one 1% Triton X-100 extraction were performed to remove contaminat- 
ing E. coli proteins, and the c13 protein was solubilized with 4 M urea (4°C for 30 rain). 
The urea was then removed by dialysis at 4°C and stored in 50 mM Tris-HCl, pH 8.0, 1 
mM EDTA. 
Induction  of Secondary  CTL  In  Vitro.  Secondary CTL  were  prepared  as  described 
previously (9).  Briefly, spleen cells from mice immunized with virus were cultured with 
syngeneic normal spleen cells  infected with  the virus or exposed to c13 protein (12.5 
#g/ml) at 37°C for 5 d. After several washings, they were used as effector cells. 
CTL Assay.  P815 cells (H-2  d) and BW5147 cells (H-2  k) were used as target cells.  In 
preliminary experiments, we  observed that  P815  and  BW5147  cells  exposed to  c13 
protein (12 ~g/ml) expressed membrane antigen(s), detected by indirect immunofluores- 
cence with a specific antiserum to c13 protein, but P815 and BW5147 cells not treated 
with c13 did not. In the CTL assay,  target cells infected with virus, or exposed to c13 
protein diluted  in  RPMI  medium,  were  labeled  with  Na25~CrO4, and  incubated  with 
effector cells at various effector/target (E/T) ratios in a 96-well round-bottom microplate 
at 37°C for 4 h in a standard 51Cr-release assay, as described earlier (9). 
Cold-target Inhibition  Test.  P815 cells infected with various viruses or treated with c 13 
protein  (12.5  t~g/ml)  at  37°C  for  90  min  were  added  to  the  CTL assay  at  various 
concentrations. The CTL assay was performed as described below. 
Blocking of Cytotoxicity by Anti-H-2  a Monoclonal Antibody (mAb).  Various target cells were 
incubated with anti-H-2  a mAb (Litton Bionetics, Charleston, SC) at 37°C for 30 rain, and 
then were incubated with appropriate effector cells at 37°C for 4 h. Antibody was used 
at 1:20 dilution (final), based on the results of a preliminary experiment. Cytotoxicity was 
determined as described above. 
Results 
Influenza  Virus-specific Lysis of Target Cells Exposed to c13.  We examined the 
ability of c 13 protein to render P815 cells susceptible to influenza virus-specific 
CTL. Effector cells were generated by stimulation of PR8 virus-immune spleen 
cells  with  PR8  virus-infected  syngeneic  spleen  cells,  and  by  c13  protein.  As 
shown  in  Fig.  1,  c13  protein-coated P815  cells were lysed by PR8  virus- and 
c l 3  protein-induced CTL, although  the level of lysis was below that of virus- 
infected target  cells.  The  level  of lysis  of cl 3  protein-coated  target  cells  was 
dose-dependent up to a concentration of 3 ~g/ml (data not shown). These results, 
(Fig.  1) suggested that target cells exposed to c 13 protein displayed an H 1 virus 
subtype-specific determinant,  since  c13  protein  has  been shown  (9)  to induce 
H1  subtype-specific CTL.  We therefore prepared two different effector cells, 
PR8  virus-stimulated  PR8  virus-immune  spleen cells,  and  A/PC  virus-stimu- 
lated  A/PC  virus-immune  spleen  cells.  Both  PR8-immune  effectors and  PC- 
immune effectors specifically lysed PR8 virus-infected target cells; (e.g., 63.8% 
and  66.2%,  respectively, at  E/T  ratios  of  10:1);  however, c13  protein-coated 
target cells showed little lysis by A/PC virus-induced A/PC virus-immune spleen 
cells, (2.8% at E/T  10:1), whereas they were definitely susceptible to PR8 virus- 
stimulated PR8 virus-immune spleen cells (34.0% at E/T  10:1). These findings 
suggest  that  c13  protein-coated  target  cells  were  lysed by  PR8  virus-specific 
CTL, but not by either crossreactive or A/PC virus-specific CTL. 1722  YAMADA ET  AL.  BRIEF  DEFINITIVE REPORT 
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FmUaE  1.  Lysis  of P815 target cells infected with PR8 virus, exposed to c13 protein, or 
untreated target cells (Nil). These target ceils were incubated with PR8 virus-immune spleen 
cells stimulated with virus (©) or c13 protein (A). Unstimulated PR8 virus-immune spleen 
cells (l-I) were also used as effectors. 
Cold-target  Inhibition  Study.  To  further  examine  the  antigen  specificity of 
effector cells recognizing target cells coated with c 13 protein, we tried to inhibit 
the killing activity of effector cells  by cold target cells.  Lysis of c13  protein- 
coated  51Cr-labeled  target  cells  was  inhibited  by  both  PR8  virus-  and  A/BZ 
virus-infected cold target cells, as well as by c13 protein-coated target cells (Fig. 
2).  A/X31  virus-infected "~lCr-labeled target cells were not lysed by PR8 virus- 
induced effector cells in the presence of all cold target cells infected with type A 
viruses, but were lysed in the presence of c 13 protein-coated or uninfected cold 
target  cells.  These  findings  indicate  that  c13  protein-coated  target  cells  are 
recognized and lysed by H 1 virus subtype-specific CTL. 
H-2-restricted  Killing  of c13  Protein-coated  Target  Cells.  We  attempted  to 
determine  whether  there  was  H-2  restriction  of killing of c13  protein-coated 
target cells.  Effector cells were obtained from BALB/c (H-2 d) and C3H (H-2 k) 
mice  immunized with  PR8  virus at  least  3  wk  before.  After stimulation  with 
virus-infected syngeneic spleen cells, cytotoxicity was examined on virus-infected 
and c13  protein-coated  P815  (H-2 a) and  BW5147  (H-2 k) cells.  Table  I  shows 
that the  lysis of virus-infected target cells was definitely restricted by the  H-2 
complex.  The  lysis of P815  cells  coated  with  c13  protein  was  manifested  by 
effector cells from BALB/c mice, but not by those from C3H mice. To further 
examine  a  possible  association  of  c13  protein  with  the  H-2  a  molecule,  we 
attempted to block the killing of c 13 protein-coated P815 cells by H-2 d effector 
cells using mAb directed to H-2K  d and -D  a.  As shown in Table  II, the lysis of 
P815 cells infected with PR8 virus by BALB/c-derived effector cells was reduced 
in the presence of anti-H-2  d mAb. The anti-H-2  d mAb inhibited BALB/c effec- 
tor-mediated lysis ofcl 3 protein-coated P815 cells, but did not affect the killing 
of PR8  virus-infected  BW5147  cells  by C3H-derived  effectors.  These  results 
strongly suggest that c l 3 protein is recognized by influenza virus-specific CTL 
in  conjunction  with  H-2K  a  or  -D d  molecules.  BW5147  cells  coated  with  c13 
protein were not sensitive to the lytic activity of C3H-derived effector cells, even 
though they could lyse PR8 virus-infected BW5147 cells (Table I). 
Discussion 
We  have  shown  that  P815  cells coated  with c13  protein,  which is  a  hybrid YAMADA  ET  AL.  BRIEF  DEFINITIVE  REPORT  1723 
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cells. 51Cr-labeled  P815 cells infected with A/X31  virus were also included in this experiment. 
TABLE  I 
H-2-restricted Lysis of cl3 Protein-coated  P815 Cells 
Target  E/T ratio 
Percent specific lysis by 
effectors* 
BALB/c 
(H.2d)  C3H (H-2  k) 
PR8-P815 
c13-P815 
PR8-BW5147 
c13-BW5147 
30  57.2  -1.6 
10  55.3  0.0 
3  36.1  0.0 
30  34.6  1.8 
10  21.0  1.2 
3  11.8  -2.2 
30  2.6  38.7 
10  -1.6  31.8 
3  1.2  17.9 
30  0.5  4.6 
10  -1.7  0.0 
3  -1.3  -1.2 
* Obtained by subtraction of lysis of untreated target cells by each group of effector 
cells. 
protein of the first 81  amino acids of NS1  and HA2 of PR8 virus, are lysed by 
influenza virus-specific CTL. Lysis of c 13 protein-coated target cells was accom- 
plished by CTL induced by virus strains of the H 1 but not the H3 subtype. Cold- 
target  inhibition  analysis  clearly  demonstrated  that  c13  protein-coated  target 
cells were recognized and killed  by an H 1 subtype-specific  population of CTL, 
confirming  our previous finding (9) that cl 3  protein  has a determinant  recog- 
nized by H 1 subtype-specific  CTL. 
Morein  et al.  (3) showed that liposomes containing  the surface glycoproteins 
of Semliki  Forest  virus  could sensitize  target  cells  to  CTL  in  the  presence  of 
inactivated Sendai virus. Sendal virus, which has a potent protein, UV-inactivated 
virions  (2),  and  the  hemagglutinin-neuraminidase  (HN)  and  F  proteins,  have 
been  shown  (4)  to make  target  cells  sensitive  to CTL  killing  when  introduced 
into  target  cells  in  liposome  vehicles.  Koszinowsky  et  al.  (10)  reported  killing 
mediated by influenza virus-specific crossreactive CTL if target cells were fused 1724  YAMADA  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Effect of Anti-H-2 a mAb on Lysis of cl3 Protein-coated Target Cells 
Percent specific lysis in the 
Effector  Target  E/T ratio  presence of:* 
SP2/0  Anti-H-2  a 
BALB/c  PR8-P815  10  57.4  48.9 (14.8) 
3  41.4  36.2 (12.6) 
c13-P815  30  43.3  26.8 (38.1) 
10  22.2  10.6 (52.3) 
3  9.3  6.9 (25.8) 
C3H  PR8-BW5147  10  48.0  45.5 (5.2) 
3  22.3  23.0(-3.1) 
* PR8 virus-infected and c- 13 coated target cells were incubated with a  1:20 dilution 
of anti-H-2  d mAb, or with the supernatant fluid obtained from culture of parental 
SP2/0  cells at  37°C  for  30  min,  then  incubated  with  effector  cells.  Percent 
inhibition of killing is indicated in the parentheses. 
to liposomes containing influenza virus surface glycoproteins, HA and neuramin- 
idase (NA). 
As far as we know,  there  have been  no successful reports  of making  target 
cells sensitive to CTL specific for viral proteins without using liposomes. In this 
regard,  it  was somewhat  unexpected to observe killing  of c13  protein-coated 
P815 cells. The HA2 portion of c 13 protein  has a  long hydrophobic tail on its 
carboxy-terminal end (11); therefore, it is conceivable that this hydrophobic end 
can  be  embedded  into  the  plasma  membrane,  although  we  do not  know  the 
precise mechanism of the interaction of c 13 protein with the cellular membrane. 
The observation (12) that the tryptic peptide of hen's egg lysozyme, which has a 
hydrophobic portion, could be presented by fixed macrophages to T  cell clones 
seems to support this concept. 
The observation that C3H (H-2  k) mouse effector cells with the ability to lyse 
PR8 virus-infected BW5147 (H-2  k) cells did not lyse c13 protein-coated  P815 
(H-2  d) cells suggests  that  lysis  of c13  protein-coated  target  cells  was  H-2  re- 
stricted. The association of c 13 protein with an H-2 molecule was also suggested 
by a blocking experiment using mAb against H-2K  d and -D  d molecules. On the 
other hand, it is of interest that c 13 protein-coated BW5147 cells were resistant 
to CTL derived from both  H-2-compatible and -incompatible  mice.  Since c l 3 
protein could be detected on the surface of BW5147 cells by immunofluorescent 
study using specific antibody to cl 3 protein (our unpublished observation), it is 
conceivable that influenza virus-specific, H-2k-restricted CTL cannot recognize 
c13  protein  in  conjunction  with  H-2  k molecules.  Selected  use  of certain  H-2 
molecules as restriction elements by CTL has been reported (13). 
In conclusion, we have demonstrated that a particular protein produced in E. 
coli renders target cells susceptible to influenza virus H 1 subtype-specific CTL. 
These approaches should provide us with more details concerning the antigenic 
specificity of virus-specific CTL and the interaction between viral antigen(s) and 
MHC product(s). 
Summary 
We have tested the ability of the c 13 protein, which is a hybrid protein of the 
first 81 amino acids of the viral nonstructural protein (NS 1) and the HA2 subunit 
of viral hemagglutination  produced in E.  coli,  to render target cells susceptible 
to the lytic activity of influenza  virus-specific cytotoxic T  lymphocytes (CTL). 
The results showed that  P815 cells coated with c13 protein were lysed by PR8 YAMADA ET  AL.  BRIEF  DEFINITIVE  REPORT  1725 
virus-induced secondary CTL derived from BALB/c mice.  Cold-target inhibi- 
tion tests clearly demonstrated  that c l 3  protein-coated P815  cells were recog- 
nized  by  an  H1  subtype-specific  CTL  population.  Furthermore,  PR8  virus- 
induced  CTL  derived from C3H  mice did  not  lyse c13  protein-coated  P815 
cells, suggesting that cl 3 protein was recognized by CTL in conjunction with H- 
2 d products. These findings suggest that this protein interacts with the cellular 
plasma  membrane and makes target cells recognizable by H-2-restricted, influ- 
enza virus subtype-specific CTL. 
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